{"id":"https://openalex.org/W4322769903","doi":"https://doi.org/10.1158/1538-7445.sabcs22-p5-14-03","title":"Abstract P5-14-03: Clonal hematopoiesis of indeterminate potential after (neo)adjuvant chemotherapy versus endocrine therapy for early breast cancer: the CIRCE-eBC prospective cohort study","display_name":"Abstract P5-14-03: Clonal hematopoiesis of indeterminate potential after (neo)adjuvant chemotherapy versus endocrine therapy for early breast cancer: the CIRCE-eBC prospective cohort study","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4322769903","doi":"https://doi.org/10.1158/1538-7445.sabcs22-p5-14-03"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs22-p5-14-03","doi":"https://doi.org/10.1158/1538-7445.sabcs22-p5-14-03","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-14-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052971671","display_name":"Stefania Morganti","orcid":"https://orcid.org/0000-0001-5284-9944","observed_orcids":["https://orcid.org/0000-0001-5284-9944"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefania Morganti","raw_affiliation_strings":["1Dana-Farber Cancer Institute; Harvard Medical School; Broad Institute of MIT and Harvard","Dana-Farber Cancer Institute","Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute; Harvard Medical School; Broad Institute of MIT and Harvard","institution_ids":["https://openalex.org/I107606265","https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008682981","display_name":"Qingchun Jin","orcid":"https://orcid.org/0000-0001-6388-5123","observed_orcids":["https://orcid.org/0000-0001-6388-5123"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qingchun Jin","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102799583","display_name":"Katheryn Santos","orcid":"https://orcid.org/0000-0002-3945-7644","observed_orcids":["https://orcid.org/0000-0002-3945-7644"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katheryn Santos","raw_affiliation_strings":["3Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050468541","display_name":"Christopher James Gibson","orcid":"https://orcid.org/0000-0002-3700-5310","observed_orcids":["https://orcid.org/0000-0002-3700-5310"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Gibson","raw_affiliation_strings":["4Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064407331","display_name":"Ashka Patel","orcid":"https://orcid.org/0009-0004-6128-5510","observed_orcids":["https://orcid.org/0009-0004-6128-5510"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashka Patel","raw_affiliation_strings":["5Department of Pathology, Brigham and Women\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Pathology, Brigham and Women\u2019s Hospital","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101169611","display_name":"Alex Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Wilson","raw_affiliation_strings":["6Broad Institute of MIT and Harvard"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Broad Institute of MIT and Harvard","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031813029","display_name":"Margaret S. Merrill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Merrill","raw_affiliation_strings":["7Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030654805","display_name":"Julie Vincuilla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Vincuilla","raw_affiliation_strings":["8Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Samantha Stokes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha Stokes","raw_affiliation_strings":["9Dana-Faber Cancer Institute; Broad Institute of MIT and Harvard","Dana-Faber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Dana-Faber Cancer Institute; Broad Institute of MIT and Harvard","institution_ids":["https://openalex.org/I107606265","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Faber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022530360","display_name":"Marla D. Lipsyc-Sharf","orcid":"https://orcid.org/0000-0002-4071-6383","observed_orcids":["https://orcid.org/0000-0002-4071-6383"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marla Lipsyc-Sharf","raw_affiliation_strings":["10Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019858534","display_name":"Tonia Parker","orcid":"https://orcid.org/0009-0008-2866-7022","observed_orcids":["https://orcid.org/0009-0008-2866-7022"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tonia Parker","raw_affiliation_strings":["11DFCI, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11DFCI, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076310424","display_name":"Tari A. King","orcid":"https://orcid.org/0000-0003-3602-2351","observed_orcids":["https://orcid.org/0000-0003-3602-2351"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tari King","raw_affiliation_strings":["12Division of Breast Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Breast Oncology Program, Dana-Farber/Brigham and Women\u2019s Cancer Center, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Division of Breast Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Breast Oncology Program, Dana-Farber/Brigham and Women\u2019s Cancer Center, Harvard Medical School","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029062544","display_name":"Elizabeth Ann Mittendorf","orcid":"https://orcid.org/0000-0002-9762-8536","observed_orcids":["https://orcid.org/0000-0002-9762-8536"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Mittendorf","raw_affiliation_strings":["13DANA-FARBER CANCER INSTITUTE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13DANA-FARBER CANCER INSTITUTE","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003897511","display_name":"Giuseppe Curigliano","orcid":"https://orcid.org/0000-0003-1781-2518","observed_orcids":["https://orcid.org/0000-0003-1781-2518"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Curigliano","raw_affiliation_strings":["14European Institute of Oncology, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14European Institute of Oncology, Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015055171","display_name":"Melissa E. Hughes","orcid":"https://orcid.org/0000-0001-6190-9101","observed_orcids":["https://orcid.org/0000-0001-6190-9101"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa E. Hughes","raw_affiliation_strings":["15Dana Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Dana Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062515397","display_name":"Nabihah Tayob","orcid":"https://orcid.org/0000-0001-6088-167X","observed_orcids":["https://orcid.org/0000-0001-6088-167X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nabihah Tayob","raw_affiliation_strings":["16Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy U. Lin","raw_affiliation_strings":["17Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090425082","display_name":"Peter Grant Miller","orcid":"https://orcid.org/0000-0002-6797-9335","observed_orcids":["https://orcid.org/0000-0002-6797-9335"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Miller","raw_affiliation_strings":["18Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"18Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069056507","display_name":"Sara M. Tolaney","orcid":"https://orcid.org/0000-0002-5940-8671","observed_orcids":["https://orcid.org/0000-0002-5940-8671"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Tolaney","raw_affiliation_strings":["19Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"19Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005206482","display_name":"Judy Ellen Garber","orcid":"https://orcid.org/0000-0001-9449-3982","observed_orcids":["https://orcid.org/0000-0001-9449-3982"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judy Garber","raw_affiliation_strings":["20Breast Oncology Program, Dana-Farber/Brigham and Women\u2019s Cancer Center, Harvard Medical School, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"20Breast Oncology Program, Dana-Farber/Brigham and Women\u2019s Cancer Center, Harvard Medical School, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088801158","display_name":"Heather Anne Parsons","orcid":"https://orcid.org/0000-0001-8178-6612","observed_orcids":["https://orcid.org/0000-0001-8178-6612"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather A. Parsons","raw_affiliation_strings":["21Dana Farber Cancer Institute; Harvard Medical School, Boston, Massachusetts","Dana Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21Dana Farber Cancer Institute; Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Dana Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"5_Supplement","first_page":"P5","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.020400000736117363,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clonal-hematopoiesis-of-indeterminate-potential","display_name":"clonal hematopoiesis of indeterminate potential","score":0.9990000128746033},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.8180000185966492},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.8259999752044678},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.9079999923706055},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.8190000057220459},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.6629999876022339},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9049999713897705},{"id":"https://openalex.org/keywords/hematologic-malignancy-risk","display_name":"hematologic malignancy risk","score":0.640999972820282},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8582578301429749},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6727103590965271},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.659212589263916},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6329344511032104},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5429472923278809},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5209685564041138},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.5209099650382996},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42273759841918945},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36952948570251465}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs22-p5-14-03","doi":"https://doi.org/10.1158/1538-7445.sabcs22-p5-14-03","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-14-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4390660487","https://openalex.org/W4367311704","https://openalex.org/W4405050002","https://openalex.org/W4365135551","https://openalex.org/W4399322924","https://openalex.org/W7167830522","https://openalex.org/W2917674690","https://openalex.org/W4406501693","https://openalex.org/W7155156254","https://openalex.org/W4386506705"],"abstract_inverted_index":{"Abstract":[0],"Clonal":[1,22,717],"hematopoiesis":[2,23,718],"of":[3,24,36,57,64,80,91,122,133,141,156,227,286,331,353,379,402,435,533,589,606,615,627,629,636,652,659,719,740],"indeterminate":[4,25,720],"potential":[5,26,721],"after":[6,126,722],"(neo)adjuvant":[7,100,128,723],"chemotherapy":[8,52,724],"versus":[9,725],"endocrine":[10,106,726],"therapy":[11,107,727],"for":[12,372,528,609,728],"early":[13,47,729],"breast":[14,48,730],"cancer:":[15,731],"the":[16,62,76,154,284,579,604,613,732,741],"CIRCE-eBC":[17,580,733],"prospective":[18,734],"cohort":[19,95,109,188,216,224,246,297,323,345,385,414,460,479,484,491,499,565,575,735],"study":[20,736],"Background:":[21],"(CHIP)":[27],"is":[28,69,73,601,663],"an":[29],"age-related":[30],"condition":[31],"associated":[32,633,648],"with":[33,46,93,102,355,399,507,617,624,634,649],"higher":[34,249],"risk":[35,56,626,651],"hematologic":[37],"malignancies,":[38],"cardiovascular":[39],"disease,":[40],"and":[41,78,125,150,177,183,206,237,258,304,312,317,325,374,455,462,481,493,530,561,571,612,620,643,656,665],"all-cause":[42],"mortality.":[43,621],"Patients":[44],"(pts)":[45],"cancer":[49],"(eBC)":[50],"receiving":[51,99,113,276,427],"(CT)":[53],"have":[54,433,646],"increased":[55],"treatment-related":[58],"myeloid":[59],"neoplasms":[60],"(tMN);":[61],"benefit":[63],"CT":[65,101,129,277,428,541,582,631],"in":[66,82,180,187,215,223,245,274,322,344,384,413,452,459,478,483,490,498,554,564,574,603,641],"eBC":[67,83,241,610],"pts":[68,92,98,112,179,214,228,275,354,426,458,466,477,487,495,611],"often":[70],"limited.":[71],"Little":[72],"known":[74,625],"about":[75],"prevalence":[77,330,401],"dynamics":[79],"CHIP":[81,152,357,382,403,409,590,616],"pts.":[84],"Methods:":[85],"We":[86,137,174],"prospectively":[87],"identified":[88],"two":[89],"cohorts":[90,181],"eBC:":[94],"A":[96,182,189,225,247,324,346,388,415,461,480,492],"\u2013":[97,111,394],"or":[103,130],"without":[104,467],"adjuvant":[105,134],"(ET);":[108],"B":[110,217,326,349,367,386,500],"ET":[114,135,539,597],"only.":[115],"Blood":[116],"was":[117,270,290,314,340,361,389,542,632],"collected":[118],"prior":[119],"to":[120,432,587],"initiation":[121],"treatment":[123],"(T1)":[124],"either":[127],"6-18":[131],"months":[132],"(T2).":[136],"performed":[138,273],"targeted":[139],"sequencing":[140],"cryopreserved":[142],"peripheral":[143],"blood":[144],"mononuclear":[145],"cell":[146],"(PBMC)-derived":[147],"genomic":[148],"DNA":[149],"defined":[151,333],"as":[153],"presence":[155],"\u22651":[157],"pathogenic":[158,288,441,468,536,639],"somatic":[159],"mutation":[160],"at":[161,336,342,359,411,444,450,470,474,504],"variant":[162],"allele":[163],"fraction":[164],"(VAF)":[165],"\u22650.02.":[166],"In":[167,296,578],"additional":[168,667],"analyses":[169],"we":[170,439],"used":[171],"VAF\u22650.005.":[172],"Results:":[173],"enrolled":[175],"118":[176],"116":[178],"B,":[184,463],"respectively.":[185,464],"Pts":[186,244,506],"were":[190,416,429,448,553],"younger":[191],"(median":[192,521],"age":[193,373,520,529],"51":[194],"vs":[195,203,210,254,263,279,293,348,366,387,510,513,523,540,596],"57,":[196],"p<":[197,256,265,281],"0.001),":[198,282],"less":[199],"frequently":[200,272],"Caucasian":[201],"(83.9":[202],"96.6%;":[204],"p=0.005)":[205],"former/current":[207],"smokers":[208],"(28.0":[209],"43.1%,":[211],"p=0.038).":[212],"All":[213],"had":[218,229,232,235,239,248,501,516],"hormone":[219],"receptor-positive":[220],"(HR+)":[221],"eBC;":[222],"50%":[226],"HR+/HER2-,":[230],"16%":[231],"HR+/HER2+,":[233],"8.5%":[234],"HR-/HER2+":[236],"25.4%":[238],"HR-/HER2-":[240],"(p<":[242,327,404],"0.001).":[243,328,405],"stage":[250],"(stage":[251],"II-III":[252],"68.7":[253],"27.6%;":[255],"0.001)":[257,266],"grade":[259],"(grade":[260],"3":[261],"65.3":[262],"15.5%;":[264],"tumors.":[267],"Genetic":[268],"testing":[269],"more":[271,430],"(88.1":[278],"68.1%,":[280],"though":[283],"rate":[285],"germline":[287],"variants":[289,358,383,410,442,469,503,509,537,552,640],"similar":[291,341,363,517],"(13.5":[292],"17.7%,":[294],"p=0.079).":[295],"A,":[298],"38%":[299],"received":[300],"anthracyclines,":[301],"7%":[302],"platinum":[303],"57%":[305],"anthracycline/platinum-sparing":[306],"CT.":[307],"Median":[308],"time":[309],"between":[310],"T1":[311,343,451,471],"T2":[313,360,412,475],"189.5":[315],"(150,406)":[316],"280":[318],"(147,":[319],"425)":[320],"days":[321],"The":[329,654],"CHIP,":[332],"by":[334],"mutations":[335],"VAF":[337,445],"\u2265":[338],"0.02,":[339],"(14.4%)":[347],"(18.1%)":[350],"(p=0.556).":[351],"Number":[352],"new":[356,381,408,502,508,535],"also":[362],"(A":[364],"3.4%":[365],"6.0%)":[368],"(p=0.373).":[369],"After":[370,526],"adjusting":[371],"stage,":[375,531],"odds":[376],"ratio":[377],"(OR)":[378],"developing":[380,534],"1.28":[390],"(95%":[391,544],"CI":[392,545],"0.32":[393],"5.68,":[395],"p=0.733).":[396],"Age":[397],"correlated":[398],"baseline":[400],"Most":[406,548],"frequent":[407,549],"DNMT3A":[417,555,567],"(3),":[418,568],"PPM1D":[419,557,642],"(1),":[420],"NF1":[421],"(1).":[422],"To":[423],"investigate":[424],"whether":[425],"likely":[431],"emergence":[434,588,635],"small":[436,661],"hematopoietic":[437],"clones,":[438],"assessed":[440],"present":[443],"\u22650.005.":[446],"These":[447],"detected":[449,551],"55":[453],"(46.6%)":[454],"61":[456],"(52.6%)":[457],"Few":[465],"developed":[472],"them":[473],"(3":[476],"4":[482],"B).":[485],"21":[486],"(27":[488],"variants)":[489,497],"11":[494],"(12":[496],"T2.":[505],"not":[511,585],"(32":[512],"202":[514],"pts)":[515],"characteristics,":[518],"excepting":[519],"60.5":[522],"54.0,":[524],"p=0.011).":[525],"correcting":[527],"OR":[532],"given":[538],"0.25":[543],"0.10-0.62,":[546],"p=0.003).":[547],"newly":[550],"(14),":[556],"(5),":[558],"TET2":[559,569],"(4)":[560],"TP53":[562],"(2)":[563,573],"A;":[566],"(3)":[570],"ZNF318":[572],"B.":[576],"Conclusions:":[577],"study,":[581],"administration":[583],"did":[584],"lead":[586],"over":[591],"a":[592],"6-9":[593],"month":[594],"period":[595],"alone.":[598],"This":[599],"finding":[600],"reassuring":[602],"setting":[605],"long":[607],"life-expectancy":[608],"association":[614],"significant":[618],"morbidity":[619],"However,":[622],"consistent":[623],"development":[628],"MN,":[630],"low":[637],"frequency":[638],"TP53,":[644],"which":[645],"been":[647],"elevated":[650],"tMN.":[653],"evolution":[655],"prognostic":[657],"role":[658],"these":[660],"clones":[662],"unclear":[664],"warrants":[666],"investigation.":[668],"Citation":[669],"Format:":[670],"Stefania":[671],"Morganti,":[672],"Qingchun":[673],"Jin,":[674],"Katheryn":[675],"Santos,":[676],"Christopher":[677],"Gibson,":[678],"Ashka":[679],"Patel,":[680],"Alex":[681],"Wilson,":[682],"Margaret":[683],"Merrill,":[684],"Julie":[685],"Vincuilla,":[686],"Samantha":[687],"Stokes,":[688],"Marla":[689],"Lipsyc-Sharf,":[690],"Tonia":[691],"Parker,":[692],"Tari":[693],"King,":[694],"Elizabeth":[695],"A.":[696,715],"Mittendorf,":[697],"Giuseppe":[698],"Curigliano,":[699],"Melissa":[700],"E.":[701],"Hughes,":[702],"Nabihah":[703],"Tayob,":[704],"Nancy":[705],"U.":[706],"Lin,":[707],"Peter":[708],"Miller,":[709],"Sara":[710],"Tolaney,":[711],"Judy":[712],"Garber,":[713],"Heather":[714],"Parsons.":[716],"[abstract].":[737],"In:":[738],"Proceedings":[739],"2022":[742,748],"San":[743,751],"Antonio":[744],"Breast":[745],"Cancer":[746,757],"Symposium;":[747],"Dec":[749],"6-10;":[750],"Antonio,":[752],"TX.":[753],"Philadelphia":[754],"(PA):":[755],"AACR;":[756],"Res":[758],"2023;83(5":[759],"Suppl):Abstract":[760],"nr":[761],"P5-14-03.":[762]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-03-03T00:00:00"}